Stocks
AbbVie’s Skyrizi Expands Pediatric Indication to Psoriatic Diseases
AbbVie's Skyrizi has received US FDA approval for children aged six and older with moderate-to-severe plaque psoriasis or active psoriatic arthritis. This...
Latest Headlines 2711 articles
Finance
JPMorgan Chase Doubles Community Centers in Low-Income Areas, Adds 150 Staff
JPMorgan Chase announced plans to significantly expand its 'Community Center' program, doubling specialized branches in low-income neighborhoods and hiring 150 new community...
Markets
Oil Prices Plunge as Supply Fears Dissipate
Oil prices dropped sharply on Thursday, erasing all gains since the Middle East conflict, driven by progress in U.S.-Iran talks and improved...
Markets
Layoffs, Acquisitions Reshape Tech: SpaceX Becomes AI Company
Recent tech layoffs at Meta, Rivian, and Robinhood spark debate over their long-term efficacy, while Fox acquires Roku and SpaceX enters the...
Finance
GigSafe, U.S. Bank Partner for Instant Driver Payments in Regulated Logistics
GigSafe has integrated U.S. Bank's embedded payment solutions, enabling instant payouts to delivery drivers within its compliance and payments platform. This partnership...
Stocks
Nasdaq Notifies Orion Digital of Bid Price Deficiency
Orion Digital Corp. (NASDAQ:ORIO) received a notification from Nasdaq regarding its common shares trading below the US$1.00 minimum bid price for 30...
Stocks
U.S. Crude Futures Top $70 After Iran Strikes
U.S. crude oil futures rose above $70/bbl post-market after American military strikes in Iran, responding to Iran's attack on a cargo ship...
Economy
Trump Threatens 100% Tariffs on Europe Over Digital Tech Taxes
Trump vows 100% tariffs on European nations implementing digital services taxes on US tech giants. The UK's existing 2% DST generated over...
Stocks
MTA Shares Break Above 200-Day Average, Signaling Bullish Trend
Metalla Royalty & Streaming Ltd (MTA) shares surged 6.7% on Friday, crossing above their 200-day moving average of $7.26 to hit $7.45,...
Markets
Eli Lilly’s Valuation: Blockbuster Drug vs. Top Analyst Picks
Eli Lilly benefits from a blockbuster weight loss drug, yet The Motley Fool Stock Advisor did not include LLY in its top...
Stocks
Hog Futures Climb on Friday After USDA Report
Lean hog futures saw notable gains on Friday, reacting to the latest USDA Hogs and Pigs report. Total hog inventory was down...
Investing
Stablecoin Depegging: MIM’s 50% Drop Spurs Alarm
Abracadabra's Magic Internet Money (MIM) stablecoin plunged 50% below its $1 peg, triggering emergency measures and renewing concerns over stablecoin stability and...